Thirty years in pharmaceutical manufacturing have shaped A&Z Pharmaceutical into a contract production partner capable of handling everything from early-stage single-product development through to high-volume commercial output. The company operates a 175,000 square foot facility equipped with cutting-edge manufacturing technology, giving clients access to large-scale, regulated production capacity without the capital burden of building it themselves.
A&Z Pharmaceutical provides end-to-end pharmaceutical manufacturing services covering formulation, production, and supply to clients across the global medicines and dietary supplement market. The integrated offering supports both pharmaceutical product lines and the growing supplement category, reflecting the dual demands placed on contract manufacturers serving health-oriented markets. Quality standards are maintained across every stage, with scientists, technicians, data specialists, managers, and administrative staff collectively forming a workforce of more than 600 employees.
The company was founded and is led by Emma Li Xu, whose entrepreneurial record has been recognised through business awards and honours in both the United States and China. Under her leadership, the company's stated mission centres on delivering an uncompromising standard of excellence in pharmaceutical manufacturing, with the broader aim of helping to bring life-changing therapies to patients worldwide.
Further information is available at azpharmaceutical.com.